Home NDC 0480-2357 Topiramate
Product NDC 0480-2357
11-digit product format 004802357
Labeler code 0480
Product ID 0480-2357_2351e0f7-3f55-4580-b424-0c76c4d9670a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Topiramate
Dosage form CAPSULE, EXTENDED RELEASE
Route ORAL
Labeler Teva Pharmaceuticals, Inc.
Application ANDA206210
Marketing category ANDA
Marketing start 2023-05-03
Substance TOPIRAMATE
Active strength 50 mg/1
Pharmacologic classes Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes NDC auxiliary status# These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
Current NDC status page 1 of 1 · 2 matching rows.
Dataset, Scope, Product NDC table Dataset Scope Product NDC Package NDC Code Status Reporting period Source date unfinished product product 0480-2357 UNFINISHED Active or certified unfinished drug listing 2026-11-16 unfinished package package 0480-2357 0480-2357-99 UNFINISHED Active or certified unfinished drug listing 2026-11-16
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 28 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 21:27 UTC · source 2025-12-05 unfinished product product a6255e0c9aa5…a0211a219f2e…2025-12-14 21:27 UTC · source 2025-12-05 unfinished package package 0480-2357-99 a6255e0c9aa5…a0211a219f2e…2025-08-26 23:59 UTC · source 2025-08-26 unfinished product product 1d862106b807…00c93037cd84…2025-08-26 23:59 UTC · source 2025-08-26 unfinished package package 0480-2357-99 1d862106b807…00c93037cd84…2025-05-15 14:59 UTC · source 2025-05-14 unfinished product product 390b4c401c3f…2c692c2daee3…2025-05-15 14:59 UTC · source 2025-05-14 unfinished package package 0480-2357-99 390b4c401c3f…2c692c2daee3…2025-04-01 07:37 UTC · source 2025-03-31 unfinished product product e30019b0c005…a3f0b14938b7…2025-04-01 07:37 UTC · source 2025-03-31 unfinished package package 0480-2357-99 e30019b0c005…a3f0b14938b7…2025-03-01 13:19 UTC · source 2025-02-28 unfinished product product bbbc9f937eca…946b9c97cf81…2025-03-01 13:19 UTC · source 2025-02-28 unfinished package package 0480-2357-99 bbbc9f937eca…946b9c97cf81…2025-02-27 05:24 UTC · source 2025-02-26 unfinished product product f268b84574a6…26285f5ac5df…2025-02-27 05:24 UTC · source 2025-02-26 unfinished package package 0480-2357-99 f268b84574a6…26285f5ac5df…2025-02-01 13:13 UTC · source 2025-01-31 unfinished product product f764e8902f78…92046438deef…2025-02-01 13:13 UTC · source 2025-01-31 unfinished package package 0480-2357-99 f764e8902f78…92046438deef…2025-01-20 13:05 UTC · source 2025-01-17 unfinished product product 68b1e3bced9e…98a755eb8bc6…2025-01-20 13:05 UTC · source 2025-01-17 unfinished package package 0480-2357-99 68b1e3bced9e…98a755eb8bc6…2024-11-29 20:42 UTC · source 2024-11-29 unfinished product product 05c55d027831…ca05dca9dc4c…2024-11-29 20:42 UTC · source 2024-11-29 unfinished package package 0480-2357-99 05c55d027831…ca05dca9dc4c…2024-11-09 02:36 UTC · source 2024-11-08 unfinished product product 48b4f40e6753…c7c7a00d2afa…2024-11-09 02:36 UTC · source 2024-11-08 unfinished package package 0480-2357-99 48b4f40e6753…c7c7a00d2afa…2024-10-09 02:27 UTC · source 2024-10-08 unfinished product product 27f29a85d7e4…1372111e901f…2024-10-09 02:27 UTC · source 2024-10-08 unfinished package package 0480-2357-99 27f29a85d7e4…1372111e901f…2024-07-10 04:00 UTC · source 2024-07-09 unfinished product product 8d62ce987f31…9fe9ef23e30d…2024-07-10 04:00 UTC · source 2024-07-09 unfinished package package 0480-2357-99 8d62ce987f31…9fe9ef23e30d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished product product d1e113ab4d42…063ee3eb0a1d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished package package 0480-2357-99 d1e113ab4d42…063ee3eb0a1d…2024-05-15 03:51 UTC · source 2024-05-14 unfinished product product 50b4072663b7…eae3003ed65e…2024-05-15 03:51 UTC · source 2024-05-14 unfinished package package 0480-2357-99 50b4072663b7…eae3003ed65e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A206210-001 TOPIRAMATE TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 A206210-002 TOPIRAMATE TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 A206210-003 TOPIRAMATE TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 A206210-004 TOPIRAMATE TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 108 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A206210-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A206210-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A206210-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A206210-004 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A206210-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 A206210-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 A206210-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 A206210-004 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 c2088c7a36db…2026-09-14 22:38:34 2026-08 A206210-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 A206210-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 A206210-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 A206210-004 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 84e616aacf4f…2026-08-18 06:07:40 2026-07 A206210-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206210-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206210-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206210-004 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A206210-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206210-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206210-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206210-004 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206210-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206210-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206210-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206210-004 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A206210-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206210-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206210-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206210-004 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206210-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206210-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206210-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206210-004 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A206210-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A206210-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A206210-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A206210-004 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A206210-001 TOPIRAMATE 25MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A206210-002 TOPIRAMATE 50MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A206210-003 TOPIRAMATE 100MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A206210-004 TOPIRAMATE 200MG CAPSULE, EXTENDED RELEASE / ORAL AB1 2023-03-10 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 3 of 3 · 108 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Topiramate
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TOPIRAMATE 50 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 0H73WJJ391 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1436239 Internal RxNorm lookup 1437278 Internal RxNorm lookup 1437283 Internal RxNorm lookup 1437288 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0480-2357-01 Topiramate 100 in 1 BOTTLE CAPSULE, EXTENDED RELEASE 100 7 0480-2357-56 Topiramate 30 in 1 BOTTLE CAPSULE, EXTENDED RELEASE 30 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0480-2357 TOPIRAMATE CAPSULE, EXTENDED RELEASE [TEVA PHARMACEUTICALS, INC.] 5 Current NDC, 2 package rows 20250510_4f20155f-05b9-40ec-af34-3b58aa8d60d4.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 0480-2357-01 00480235701 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0480-2357-01) 2023-05-03 No No Current 0480-2357-56 00480235756 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0480-2357-56) 2023-05-03 No No Current 0480-2357-99 00480235799 13800 CAPSULE, EXTENDED RELEASE in 1 CONTAINER (0480-2357-99) 10-MAR-23 Current